Fiscal Year 2025 OMUFA Facility User Fee Due Date

Jun 2, 2025

This message is in reference to the March 21, 2025, Food and Drug Administration Federal Register notice (FRN) titled “Over-the-Counter Monograph Drug User Fee Program – Facility Fee Rates for Fiscal Year 2025. ” The fiscal year (FY) 2025 Over-the-Counter (OTC) monograph drug facility user fees are due today, June 2, 2025. If you are a qualifying owner of an OTC monograph drug facility, as described in sections 744M and 744L of the Federal Food, Drug, and Cosmetic Act, please visit FDA’s payment portal to submit your payment. For more information on fee-qualifying OTC monograph drug facilities as well as fee payment options and procedures, please visit the aforementioned FRN. For more information on the OTC monograph drug user fee program (OMUFA), please visit our OMUFA user fee website.

FDA issued FY 2025 OMUFA facility user fee invoices on April 21, 2025.

If you have submitted your FY 2025 OMUFA facility user fee prior to this message, thank you for your attention to this matter and no further action is required at this time.

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.

R.G. Client

I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.

Mike H. Client

Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.

Dr. Sastry Client

I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.

Claire P. Client